Literature DB >> 17167345

No evidence for an association between variants at the gamma-amino-n-butyric acid type A receptor beta2 locus and schizophrenia.

Rami Abou Jamra1, Tim Becker, Norman Klopp, Faten Dahdouh, Thomas G Schulze, Magdalena Gross, Monika Deschner, Christine Schmäl, Thomas Illig, Marcella Rietschel, Peter Propping, Sven Cichon, Markus M Nöthen, Johannes Schumacher.   

Abstract

The alpha1/beta2/gamma2-containing heteropentamer is the most abundant gamma-amino-n-butyric acid type A receptor subtype in mammalian brains and the corresponding genes, the GABRA1, GABRB2, and GABRG2 genes, are located in chromosomal region 5q34 that several genome wide scans have implicated as a susceptibility region for schizophrenia. Given this positional and functional evidence, Lo et al. (Mol Psychiatry 2004; 9: 603-608) performed systematic linkage disequilibrium mapping of the GABAAR gene cluster on 5q34 in 130 schizophrenic patients and 170 controls, all of Chinese Han origin. In the single locus and haplotype analyses, single nucleotide polymorphisms in the GABRB2 gene showed highly significant association. The estimated effect caused by GABRB2 varied between odds ratios of 2.27 and 5.12. In order to re-examine their findings, we analyzed the most significantly associated single nucleotide polymorphism in the GABRB2 gene in a sample of 367 patients with schizophrenia and 360 controls, all of German descent. Our sample had a sufficient power to detect the effects described. Neither single marker nor haplotype analysis revealed a significant association with the disease status. Thus, our results do not support the hypothesis that genetic variation at the GABRB2 locus plays a major role in schizophrenic patients of European descent and that such variation would explain the previously observed linkage findings at this chromosomal region.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17167345     DOI: 10.1097/YPG.0b013e32801118cd

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  3 in total

1.  Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.

Authors:  Erika Pedrosa; Radu Stefanescu; Benjamin Margolis; Oriana Petruolo; Yungtai Lo; Karen Nolan; Tomas Novak; Pavla Stopkova; Herbert M Lachman
Journal:  Schizophr Res       Date:  2008-05-27       Impact factor: 4.939

2.  Positive selection within the Schizophrenia-associated GABA(A) receptor beta(2) gene.

Authors:  Wing-Sze Lo; Zhiwen Xu; Zhiliang Yu; Frank W Pun; Siu-Kin Ng; Jianhuan Chen; Ka-Lok Tong; Cunyou Zhao; Xiaojing Xu; Shui-Ying Tsang; Mutsuo Harano; Gerald Stöber; Vishwajit L Nimgaonkar; Hong Xue
Journal:  PLoS One       Date:  2007-05-23       Impact factor: 3.240

3.  Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium.

Authors:  Tian Zhang; Jun Li; Hao Yu; Yongyong Shi; Zhiqiang Li; Linyan Wang; Ziqi Wang; Tianlan Lu; Lifang Wang; Weihua Yue; Dai Zhang
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.